SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...
The next frontier in robotics will take inspiration from biology to design robots that are soft, smart, green and social. From microrobots for cancer treatment, to swarms powering warehouses, soft ...
PROCEPT BioRobotics (NASDAQ:PRCT) said it has received FDA approval to conduct a study investigating the safety and efficacy of Aquablation therapy in the treatment of prostate cancer. PROCEPT said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback